Eurazeo Patrimoine has entered into exclusive discussions with Bridgepoint to acquire the C2S private clinic group.

C2S Group is the eighth largest private clinic operator in France and a regional leader in Auvergne Rhône-Alpes and Burgundy Franche-Comté. It operates 11 clinics, primarily specializing in general medicine, surgery and obstetrics. It also owns the buildings for 7 of its clinics. The group has 500 medical practitioners and nearly 1,800 employees and reported revenue of €158 million in 2016

About Eurazeo

With a diversified portfolio of approximately ~€7 billion in assets under management, of which €1 billion is from third parties, Eurazeo is a leading global investment company with offices in Paris and Luxembourg, New York, Shanghai and Sao Paolo. Its purpose and mission is to identify, accelerate and enhance the transformation potential of the companies in which it invests. The firm covers most private equity segments through its five business divisions–Eurazeo Capital, Eurazeo Croissance, Eurazeo PME, Eurazeo Patrimoine and Eurazeo Brands. Its solid institutional and family shareholder base, robust financial structure free of structural debt, and flexible investment horizon enable Eurazeo to support its companies over the long term. As a global long-term shareholder, the firm offers deep sector expertise, a gateway to global markets, and a stable foothold for transformational growth to the companies it supports.

Eurazeo is listed on Euronext Paris.

ISIN: FR0000121121

Bloomberg: RF FP

Reuters: EURA.PA